United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 15, 2026 · Filed Jul 16, 2026

On Jul 15, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$530.35 for US$5.04M under a trading plan, leaving 324,443 shares. Filed Jul 16, 2026 (Form 4).

Sold
9,500 shares
Price
US$530.35 average (US$520.92 to US$534.27)
Value
US$5.04M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 15, 2026Common StockOption exercise1,718US$135.4242,231Direct
Jul 15, 2026Common StockSale80US$521.8242,151Direct
Jul 15, 2026Common StockSale120US$523.9742,031Direct
Jul 15, 2026Common StockSale80US$525.4341,951Direct
Jul 15, 2026Common StockSale40US$527.5541,911Direct
Jul 15, 2026Common StockSale120US$529.6641,791Direct
Jul 15, 2026Common StockSale278US$530.9741,513Direct
Jul 15, 2026Common StockSale800US$532.0640,713Direct
Jul 15, 2026Common StockSale160US$533.2240,553Direct
Jul 15, 2026Common StockSale40US$534.0940,513Direct
Jul 15, 2026Common StockOption exercise7,782US$135.42332,225Indirect
Jul 15, 2026Common StockSale48US$520.92332,177Indirect
Jul 15, 2026Common StockSale189US$521.84331,988Indirect
Jul 15, 2026Common StockSale203US$523.20331,785Indirect
Jul 15, 2026Common StockSale440US$524.40331,345Indirect
Jul 15, 2026Common StockSale280US$525.24331,065Indirect
Jul 15, 2026Common StockSale120US$527.77330,945Indirect
Jul 15, 2026Common StockSale641US$529.03330,304Indirect
Jul 15, 2026Common StockSale577US$530.12329,727Indirect
Jul 15, 2026Common StockSale1,044US$531.03328,683Indirect
Jul 15, 2026Common StockSale3,295US$531.97325,388Indirect
Jul 15, 2026Common StockSale825US$533.08324,563Indirect
Jul 15, 2026Common StockSale120US$534.27324,443Indirect

Source

View original at SEC

Related